913
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Discovery of 3CLpro Inhibitor of SARS-CoV-2 Main Protease

, , , &
Article: FSO853 | Received 12 Feb 2023, Accepted 20 Mar 2023, Published online: 06 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yi Kuang, Wenjing Shen, Xiaodong Ma, Ziwei Wang, Rui Xu, Qingqing Rao & Shengxiang Yang. (2023) In Silico Identification of Natural Compounds Against SARS-CoV-2 Main Protease From Chinese Herbal Medicines. Future Science OA 9:7.
Read now

Articles from other publishers (2)

Lei Tian, Taotao Qiang, Xiuding Yang, Yue Gao, Xiaopei Zhai, Kairui Kang, Cong Du, Qi Lu, Hong Gao, Dezhu Zhang, Xiaolin Xie & Chengyuan Liang. (2024) Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection. European Journal of Medicinal Chemistry 264, pages 115979.
Crossref
Jannatul Ferdous, Md. Ekhtiar Rahman, Farzana Sayed Sraboni, Amit Kumar Dutta, Md. Siddikur Rahman, Md. Roushan Ali, Biswanath Sikdar, Alam Khan & Md. Faruk Hasan. (2023) Assessment of the hypoglycemic and anti-hemostasis effects of Paederia foetida (L.) in controlling diabetes and thrombophilia combining in vivo and computational analysis. Computational Biology and Chemistry 107, pages 107954.
Crossref